Improvement of amyloid-related symptoms after autologous stem cell transplantation in a patient with hepatomegaly, macroglossia and purpura

Bone Marrow Transplantation

Volumn 24, Issue 4, 1999, Pages 433-435

  Patriarca, F ^a   Geromin, A ^a   Fanin, R ^a   Damiani, D ^a   Sperotto, A ^a   Baccarani, M ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

Amyloidosis AL; Autologous stem cell transplantation; Macroglossia

Indexed keywords

ALKALINE PHOSPHATASE; BUSULFAN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; MELPHALAN; MYELOABLATIVE AGENT; VINCRISTINE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; AMYLOIDOSIS; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW; CASE REPORT; CELL INFILTRATION; FEMALE; HEPATOMEGALY; HUMAN; HUMAN CELL; MACROGLOSSIA; MONOCLONAL IMMUNOGLOBULINEMIA; PLASMA CELL; PRIORITY JOURNAL; PURPURA; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032796085     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701925     Document Type: Article

References (8)

1. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. New Engl J Med 1997; 337: 898-909.
2. Perfetti V, Garini P, Vignarelli M et al. Diagnostic approach to and follow-up of difficult cases of AL amyloidosis. Haematologica 1995; 80: 409-415.
3. Kyle RA, Greipp PR. Primary systemic amyloidosis: comparison of melphalan and prednisone versus placebo. Blood 1978; 52: 818-827.
4. Kyle AR, Gertz MA, Greipp PR et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, melphalan, prednisone and colchicine. New Engl J Med 1997; 336: 1202-1207.
5. Majolino I, Marceno R, Pecoraro G et al. High dose therapy and autologous transplantation in amyloidosis-AL. Haematologica 1993; 78: 68-71.
6. Moreau P, Leblond V, Bourquelot P et al. Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis. Br J Haematol 1998; 101: 766-796.
7. Comenzo RL, Vosburgh E, Simms RW et al. Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: 1-year follow-up in five patients. Blood 1996; 88: 2801-2806.
8. Comenzo RL, Vosburgh E, Falk RH et al. Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: survival and responses in 25 patients. Blood 1998; 91: 3662-3670.